4-phenylbutyric acid promotes migration of gastric cancer cells by histone deacetylase inhibition-mediated IL-8 upregulation

被引:14
作者
Shi, Xiaonan [1 ,2 ,3 ]
Gong, Libao [1 ,2 ]
Liu, Yunpeng [1 ,2 ]
Hou, Kezuo [1 ,2 ]
Fan, Yibo [1 ,2 ]
Li, Ce [1 ,2 ]
Wen, Ti [1 ,2 ]
Qu, Xiujuan [1 ,2 ]
Che, Xiaofang [1 ,2 ]
机构
[1] First Hosp China Med Univ, Dept Med Oncol, Shenyang, Peoples R China
[2] First Hosp China Med Univ, Key Lab Anticanc Drugs & Biotherapy Liaoning Prov, Shenyang, Peoples R China
[3] Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, Zhengzhou, Henan, Peoples R China
基金
中国国家自然科学基金;
关键词
4-PBA; histone deacetylase inhibitor; histone acetylation; IL-8; EMT; gastric cancer cell; INTERLEUKIN-8; EXPRESSION; MESENCHYMAL TRANSITION; SODIUM PHENYLBUTYRATE; PATHWAY; INDEPENDENCE; COMBINATION; PROGRESSION; INDUCTION; PROGNOSIS; CARCINOMA;
D O I
10.1080/15592294.2019.1700032
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Histone acetylation is regulated by histone acetyltransferases (HATs) and histone deacetylases (HDACs). It is associated with gene transcription and expression. 4-Phenylbutyric acid (4-PBA), an HDAC inhibitor (HDACi), can inhibit cancer cell proliferation by increasing the level of histone acetylation. However, 4-PBA did not show any efficacy in clinical trials. In this study, we found that 4-PBA induced epithelial-mesenchymal transition (EMT) in gastric cancer cell lines MGC-803 and BGC-823 with ectopic E-cadherin expression. Based on the expression profile microarray, IL-8 was the most significantly up-regulated gene by 4-PBA, and was selected for further investigation. Knockdown of IL-8 partially prevented 4-PBA-induced-EMT by blocking the activation of the downstream Gab2-ERK pathway. Furthermore, CHIP assay confirmed that acetyl-H3 directly combined with the promoter region of IL-8 to promote its transcription. Therefore, the results of this study demonstrated that 4-PBA-mediated inhibition of HDAC activity could induce EMT in gastric cancer cells via acetyl-histone-mediated IL-8 upregulation, and the downstream Gab2/ERK activation. These data indicated the possible reason for the failure of 4-PBA in clinical trials.
引用
收藏
页码:632 / 645
页数:14
相关论文
共 38 条
[1]   Potentiation of tumor necrosis factor-induced NF-κB activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of IκBα [J].
Adam, E ;
Quivy, V ;
Bex, F ;
Chariot, A ;
Collette, Y ;
Vanhulle, C ;
Schoonbroodt, S ;
Goffin, V ;
Nguyên, TLA ;
Gloire, G ;
Carrard, G ;
Friguet, B ;
de Launoit, Y ;
Burny, A ;
Bours, V ;
Piette, J ;
Van Lint, CV .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (17) :6200-6209
[2]   Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer [J].
Araki, Shinako ;
Omori, Yohei ;
Lyn, Dominic ;
Singh, Rajendra K. ;
Meinbach, David M. ;
Sandman, Yekutiel ;
Lokeshwar, Vinata B. ;
Lokeshwar, Bal L. .
CANCER RESEARCH, 2007, 67 (14) :6854-6862
[3]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[4]   The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis [J].
Brat, DJ ;
Bellail, AC ;
Van Meir, EG .
NEURO-ONCOLOGY, 2005, 7 (02) :122-133
[5]   Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors [J].
Camacho, Luis H. ;
Olson, Jon ;
Tong, William P. ;
Young, Charles W. ;
Spriggs, David R. ;
Malkin, Mark G. .
INVESTIGATIONAL NEW DRUGS, 2007, 25 (02) :131-138
[6]  
Carducci MA, 2001, CLIN CANCER RES, V7, P3047
[7]   Interleukin-8 Expression Is Regulated by Histone Deacetylases through the Nuclear Factor-κB Pathway in Breast Cancer [J].
Chavey, Carine ;
Muehlbauer, Marcus ;
Bossard, Carine ;
Freund, Ariane ;
Durand, Sebastien ;
Jorgensen, Christian ;
Jobin, Christian ;
Lazennec, Gwendal .
MOLECULAR PHARMACOLOGY, 2008, 74 (05) :1359-1366
[8]   CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition [J].
Cheng, Xian-Shuo ;
Li, Yun-Feng ;
Tan, Jing ;
Sun, Bin ;
Xiao, You-Chuan ;
Fang, Xing-Bao ;
Zhang, Xiao-Feng ;
Li, Qiang ;
Dong, Jian-Hua ;
Li, Ming ;
Qian, Hai-hua ;
Yin, Zheng-Feng ;
Yang, Zhi-Bin .
CANCER LETTERS, 2014, 348 (1-2) :77-87
[9]   Cancer Epigenetics: From Mechanism to Therapy [J].
Dawson, Mark A. ;
Kouzarides, Tony .
CELL, 2012, 150 (01) :12-27
[10]   Structure and function of Gab2 and its role in cancer (Review) [J].
Ding, Chen-Bo ;
Yu, Wei-Na ;
Feng, Ji-Hong ;
Luo, Jun-Min .
MOLECULAR MEDICINE REPORTS, 2015, 12 (03) :4007-4014